Siegfried Acquires Extractas Bioscience,
Extractas Bioscience acquired by Siegfried
Get the full Extractas Bioscience company profile
Access contacts, investors, buying signals & more

Extractas Bioscience
Undisclosed Amount
January 27, 2026

Siegfried
Siegfried has acquired Extractas Bioscience, a company specializing in botanical extracts and purified products, for an undisclosed amount.
This corporate acquisition sees Siegfried taking full ownership of Extractas Bioscience, formerly known as Tasmanian Alkaloids Pty Ltd.
, marking a significant expansion in Siegfried's operational scope.
Extractas Bioscience is recognized as a world leader in the research, manufacturing, and export of botanical extracts and purified products, serving various industries with its specialized offerings.
The strategic rationale behind this acquisition centers on enhancing Siegfried's capabilities and market position.
Extractas Bioscience brings a deep expertise in the complex field of botanical extraction and purification, an area that complements Siegfried's existing operations.
This move allows Siegfried to integrate Extractas's advanced research and manufacturing processes, potentially broadening its portfolio of specialized ingredients and active pharmaceutical ingredients (APIs) derived from natural sources.
The acquisition is expected to strengthen Siegfried's ability to serve clients requiring high-quality, naturally derived compounds.
Expected synergies from the integration of Extractas Bioscience into Siegfried include expanded research and development opportunities, particularly in the realm of natural product chemistry.
The combined entity is anticipated to leverage Extractas's specialized manufacturing infrastructure and scientific knowledge with Siegfried's broader pharmaceutical expertise and global reach.
This integration aims to optimize production processes, accelerate product development cycles, and open new avenues for innovation in both existing and emerging markets.
Looking ahead, the acquisition positions the combined entity to capitalize on the growing demand for naturally sourced and highly purified products.
By bringing together Extractas Bioscience's leadership in botanical extracts with Siegfried's established presence, the companies aim to deliver enhanced value to customers and stakeholders, fostering continued growth and innovation in the specialized ingredients sector.
Unlock GTM Signals
Discover Extractas Bioscience's tech stack and active buying intent signals.
View GTM SignalsTrusted by 200+ sales professionals
Unlock Key Decision-Makers
Get direct access to the key decision-makers at Extractas Bioscience.
Unlock Decision-MakersTrusted by 200+ sales professionals